18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol

BACKGROUND AND STUDY DESIGN: Role of (18)F‐fluoro‐2‐deoxy‐2‐d‐glucose positron emission tomography‐computed tomography (FDG PET‐CT) in evaluation of renal cell cancers (RCC) and urinary bladder cancers is not standardized, and the COPPER‐T trial, which is a single centre prospective randomized study...

Descripción completa

Detalles Bibliográficos
Autores principales: Jena, Rahul, Bhargava, Priyank, Tripathi, Shashank, Taywade, Sameer, Yadav, Taruna, Sandhu, Arjun Singh, Singh, Mahendra, Navriya, Shiv Charan, Bhirud, Deepak Prakash, Aggarwal, Amit, Choudhary, Gautam Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560619/
https://www.ncbi.nlm.nih.gov/pubmed/37818027
http://dx.doi.org/10.1002/bco2.246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560619/
https://www.ncbi.nlm.nih.gov/pubmed/37818027
http://dx.doi.org/10.1002/bco2.246

Ejemplares similares